Medical Developments Earnings Call Highlights Penthrox Momentum
Bell Potter Remains a Buy on Medical Developments International Limited (MVP)
MVP: Revenue up 9% and net profit after tax rose to $0.6M, driven by Pain Management growth
Bell Potter Sticks to Its Buy Rating for Medical Developments International Limited (MVP)